Literature DB >> 21817949

Outcomes and duration of Pneumocystis jiroveci pneumonia therapy in infants with severe combined immunodeficiency.

Ingrid S Lundgren1, Janet A Englund, Lauri M Burroughs, Troy R Torgerson, Suzanne Skoda-Smith.   

Abstract

This retrospective review of patients with severe combined immunodeficiency and Pneumocystis jiroveci pneumonia (PCP) evaluated the relationship between duration of therapy to treat PCP and overall survival. We found that 80% of patients receiving only 21 days of antibiotics survived to 12 months beyond hematopoietic cell transplant, whereas only 25% of patients who required longer treatment for PCP survived to stem cell engraftment.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 21817949      PMCID： PMC3244569          DOI： 10.1097/INF.0b013e31822db772

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


  11 in total

1.  Permanent declines in pulmonary function following pneumonia in human immunodeficiency virus-infected persons. The Pulmonary Complications of HIV Infection Study Group.

Authors:  A M Morris; L Huang; P Bacchetti; J Turner; P C Hopewell; J M Wallace; P A Kvale; M J Rosen; J Glassroth; L B Reichman; J D Stansell
Journal:  Am J Respir Crit Care Med       Date:  2000-08       Impact factor: 21.405

2.  Persistent reduction in lung function after Pneumocystis carinii pneumonia in AIDS patients.

Authors:  S Nelsing; B N Jensen; V Backer
Journal:  Scand J Infect Dis       Date:  1995

3.  Unsuspected Pneumocystis carinii pneumonia at presentation of severe primary immunodeficiency.

Authors:  J E Berrington; T J Flood; M Abinun; A Galloway; A J Cant
Journal:  Arch Dis Child       Date:  2000-02       Impact factor: 3.791

4.  Pneumocystis carinii pneumonia alters expression and distribution of lung collectins SP-A and SP-D.

Authors:  E N Atochina; J M Beck; S T Scanlon; A M Preston; M F Beers
Journal:  J Lab Clin Med       Date:  2001-06

5.  Persistence of Pneumocystis carinii after effective treatment of P. carinii pneumonia is not related to relapse or survival among patients infected with human immunodeficiency virus.

Authors:  P M Roger; F Vandenbos; P Pugliese; F De Salvador; J Durant; Y Le Fichoux; P Dellamonica
Journal:  Clin Infect Dis       Date:  1998-02       Impact factor: 9.079

6.  Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  Lynne M Mofenson; Michael T Brady; Susie P Danner; Kenneth L Dominguez; Rohan Hazra; Edward Handelsman; Peter Havens; Steve Nesheim; Jennifer S Read; Leslie Serchuck; Russell Van Dyke
Journal:  MMWR Recomm Rep       Date:  2009-09-04

7.  A prospective molecular surveillance study evaluating the clinical impact of community-acquired respiratory viruses in lung transplant recipients.

Authors:  Deepali Kumar; Shahid Husain; Maggie Hong Chen; George Moussa; David Himsworth; Oriol Manuel; Sean Studer; Diana Pakstis; Kenneth McCurry; Karen Doucette; Joseph Pilewski; Richard Janeczko; Atul Humar
Journal:  Transplantation       Date:  2010-04-27       Impact factor: 4.939

8.  Severe combined immunodeficiency: a national surveillance study.

Authors:  Anthony Yee; Suk See De Ravin; Elizabeth Elliott; John B Ziegler
Journal:  Pediatr Allergy Immunol       Date:  2008-01-24       Impact factor: 6.377

9.  Human rhinovirus and coronavirus detection among allogeneic hematopoietic stem cell transplantation recipients.

Authors:  Filippo Milano; Angela P Campbell; Katherine A Guthrie; Jane Kuypers; Janet A Englund; Lawrence Corey; Michael Boeckh
Journal:  Blood       Date:  2009-12-30       Impact factor: 22.113

Review 10.  Sulfa use, dihydropteroate synthase mutations, and Pneumocystis jirovecii pneumonia.

Authors:  Cheryl R Stein; Charles Poole; Powel Kazanjian; Steven R Meshnick
Journal:  Emerg Infect Dis       Date:  2004-10       Impact factor: 6.883
View more
  4 in total

1.  Eosinophils Contribute to Early Clearance of Pneumocystis murina Infection.

Authors:  Taylor Eddens; Waleed Elsegeiny; Michael P Nelson; William Horne; Brian T Campfield; Chad Steele; Jay K Kolls
Journal:  J Immunol       Date:  2015-05-20       Impact factor: 5.422

2.  Economic Evaluation of Newborn Screening for Severe Combined Immunodeficiency.

Authors:  Sophy T F Shih; Elena Keller; Veronica Wiley; Melanie Wong; Michelle A Farrar; Georgina M Chambers
Journal:  Int J Neonatal Screen       Date:  2022-07-20

3.  Modelling the Cost-Effectiveness and Budget Impact of a Newborn Screening Program for Spinal Muscular Atrophy and Severe Combined Immunodeficiency.

Authors:  Sophy T F Shih; Elena Keller; Veronica Wiley; Michelle A Farrar; Melanie Wong; Georgina M Chambers
Journal:  Int J Neonatal Screen       Date:  2022-07-20

Review 4.  Recognition and Clinical Presentation of Invasive Fungal Disease in Neonates and Children.

Authors:  Jill King; Zoi-Dorothea Pana; Thomas Lehrnbecher; William J Steinbach; Adilia Warris
Journal:  J Pediatric Infect Dis Soc       Date:  2017-09-01       Impact factor: 3.164
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.